Innovent and Eli Lilly Partner to Commercialize Verzenios in China
Innovent Biologics and Eli Lilly have partnered to commercialize Verzenios (abemaciclib) in China, expanding access to the cancer treatment in the region.
Results for "Innovent Biologics"
4 stories found
Metalla Royalty & Streaming Reports Full-Year Results
Metalla Royalty & Streaming has announced its financial results for the full fiscal year.
Pfizer Strikes Cancer Therapy Deal with China's Innovent Biologics
Pfizer has entered into a deal worth up to $10.5 billion with China's Innovent Biologics to develop next-generation cancer therapies, marking a significant collaboration in the pharmaceutical sector.
Pfizer and Innovent Biologics Announce $10.5 Billion Oncology Deal
Pfizer has entered into a significant oncology deal with China's Innovent Biologics, valued at up to $10.5 billion. The agreement involves collaboration on 12 cancer drug trials, boosting Innovent Biologics' shares.